Development of Small RNA Delivery Systems for Lung Cancer Therapy
RNA interference (RNAi) has emerged as a powerful tool for studying target identification and holds promise for the development of therapeutic gene silencing. Recent advances in RNAi delivery and target selection provide remarkable opportunities for translational medical research. The induction of R...
Main Authors: | Yu Fujita, Kazuyoshi Kuwano, Takahiro Ochiya |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/16/3/5254 |
Similar Items
-
RNAi Therapeutic Platforms for Lung Diseases
by: Kazuyoshi Kuwano, et al.
Published: (2013-02-01) -
Nanoparticles as Drug Delivery Systems in Cancer Medicine: Emphasis on RNAi-Containing Nanoliposomes
by: Pablo E. Vivas-Mejia, et al.
Published: (2013-11-01) -
GENDEN TEDAVİYE YENİ YAKLAŞIMLAR: KODLAMAYAN NÜKLEİK ASİTLER
by: Hasret Ecevit, et al.
Published: (2015-03-01) -
The RNA interference revolution
by: G. Lenz
Published: (2005-12-01) -
Nano-based delivery of RNAi in cancer therapy
by: Yong Xin, et al.
Published: (2017-07-01)